Skip to Main Content

Paper Details

GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
Acta Neuropathol
16
2021
Author NameAffiliation
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ)
Martin SillGerman Cancer Research Center (DKFZ)
Dominik SturmHopp Children's Cancer Center Heidelberg (KiTZ)
Dominik SturmGerman Cancer Research Center (DKFZ)
Dominik SturmUniversity Hospital Heidelberg
Dominik SturmHopp Children's Cancer Center Heidelberg (KiTZ)
Dominik SturmUniversity Hospital Heidelberg
Dominik SturmGerman Cancer Research Center (DKFZ)
Daniel KazdalInstitute of Pathology, University Hospital Heidelberg
Christof M KrammUniversity Medical Center Gottingen
Guido ReifenbergerInstitute of Neuropathology, Heinrich Heine University
Guido Reifenberger
David CapperCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Institute of Neuropathology
David CapperGerman Cancer Research Center (DKFZ)
David CapperCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Institute of Neuropathology
David CapperGerman Cancer Research Center (DKFZ)
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeUniversity Hospital Heidelberg
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittUniversity Hospital Heidelberg
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittUniversity Hospital Heidelberg
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterUniversity Hospital Heidelberg
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterUniversity Hospital Heidelberg
Andreas von DeimlingInstitute of Pathology, University Hospital Heidelberg
Andreas von DeimlingClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
  • 1 - 50

Datasets